HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The PHD finger of p300 influences its ability to acetylate histone and non-histone targets.

Abstract
In enzymes that regulate chromatin structure, the combinatorial occurrence of modules that alter and recognise histone modifications is a recurrent feature. In this study, we explored the functional relationship between the acetyltransferase domain and the adjacent bromodomain/PHD finger (bromo/PHD) region of the transcriptional coactivator p300. We found that the bromo/PHD region of p300 can bind to the acetylated catalytic domain in vitro and augment the catalytic activity of the enzyme. Deletion of the PHD finger, but not the bromodomain, impaired the ability of the enzyme to acetylate histones in vivo, whilst it enhanced p300 self-acetylation. A point mutation in the p300 PHD finger that is related to the Rubinstein-Taybi syndrome resulted in increased self-acetylation but retained the ability to acetylate histones. Hence, the PHD finger appears to negatively regulate self-acetylation. Furthermore, our data suggest that the PHD finger has a role in the recruitment of p300 to chromatin.
AuthorsJohannes G M Rack, Timo Lutter, Gro Elin Kjæreng Bjerga, Corina Guder, Christine Ehrhardt, Signe Värv, Mathias Ziegler, Rein Aasland
JournalJournal of molecular biology (J Mol Biol) Vol. 426 Issue 24 Pg. 3960-3972 (Dec 12 2014) ISSN: 1089-8638 [Electronic] Netherlands
PMID25158095 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Ltd. All rights reserved.
Chemical References
  • Histones
  • E1A-Associated p300 Protein
  • EP300 protein, human
Topics
  • Acetylation
  • Binding Sites (genetics)
  • Biocatalysis
  • E1A-Associated p300 Protein (chemistry, genetics, metabolism)
  • HEK293 Cells
  • HeLa Cells
  • Histones (metabolism)
  • Humans
  • Immunoblotting
  • Immunohistochemistry
  • Microscopy, Fluorescence
  • Models, Molecular
  • Point Mutation
  • Protein Binding
  • Protein Structure, Tertiary

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: